Neurosteroids and GABA A receptor interactions: A focus on stress

Frontiers in Neuroscience

Volumn , Issue DEC, 2011, Pages

  Gunn, Benjamin G ^a   Brown, A G ^a   Lambert, Jeremy J ^a   Belelli, Delia ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Allopregnanolone; Anxiety; HPA axis; Maternal care; Synaptic inhibition

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA; ANXIOLYTIC AGENT; CLONAZEPAM; DIAZEPAM; EMAPUNIL; ETIFOXINE; MIDAZOLAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEUROSTEROID; POTASSIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; UNCLASSIFIED DRUG;

ACUTE STRESS; ADRENAL CORTEX; ALZHEIMER DISEASE; ANXIETY DISORDER; CHRONIC STRESS; DEPRESSION; DORSOMEDIAL PARVOCELLULAR REGION; DOWN REGULATION; DRUG MECHANISM; EARLY LIFE STRESS; ELECTROPHYSIOLOGY; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NERVE CELL MEMBRANE CONDUCTANCE; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OVARY; PATHOGENESIS; PATHOPHYSIOLOGY; POSTNATAL STRESS; POSTSYNAPTIC INHIBITION; POSTTRAUMATIC STRESS DISORDER; PRENATAL STRESS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STRESS;

EID: 84857024927     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2011.00131     Document Type: Review

References (246)

1. Agis-Balboa, R. C., Pinna, G., Zhubi, A., Maloku, E., Veldic, M., Costa, E., and Guidotti, A. (2006). Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 103, 14602-14607.
2. Akk, G., Li, P., Bracamontes, J., Reichert, D. E., Covey, D. F., and Steinbach, J. H. (2008). Mutations of the GABA-A receptor α1 subunitM1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol. Pharmacol. 74, 614-627.
3. Akk, G., Shu, H. J., Wang, C., Steinbach, J. H., Zorumski, C. F., Covey, D. F., and Mennerick, S. (2005). Neurosteroid access to the GABAA receptor. J. Neurosci. 25, 11605-11613.
4. Alfarez, D. N., Joels, M., and Krugers, H. J. (2003). Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro. Eur. J. Neurosci. 17, 1928-1934.
5. Alfarez, D. N., Wiegert, O., Joels, M., and Krugers, H. J. (2002). Corticosterone and stress reduce synaptic potentiation in mouse hippocampal slices with mild stimulation. Neuroscience 115, 1119-1126.
6. Avishai-Eliner, S., Eghbal-Ahmadi, M., Tabachnik, E., Brunson, K. L., and Baram, T. Z. (2001). Down-regulation of hypothalamic corticotropin-releasing hormone messenger ribonucleic acid (mRNA) precedes early-life experience-induced changes in hippocampal glucocorticoid receptor mRNA. Endocrinology 142, 89-97.
7. Baghai, T. C., di Michele, F., Schule, C., Eser, D., Zwanzger, P., Pasini, A., Romeo, E., and Rupprecht, R. (2005). Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression. Neuropsychopharmacology 30,1181-1186.
8. Bajo, M., Cruz, M. T., Siggins, G. R., Messing, R., and Roberto, M. (2008). Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala. Proc. Natl. Acad. Sci. U.S.A. 105, 8410-8415.
9. Bale, T. L., Baram, T. Z., Brown, A. S., Goldstein, J. M., Insel, T. R., McCarthy, M. M., Nemeroff, C. B., Reyes, T. M., Simerly, R. B., Susser, E. S., and Nestler, E. J. (2010). Early life programming and neurodevelopmental disorders. Biol. Psychiatry 68,314-319.
10. Bale, T. L., and Vale, W. W. (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44, 525-557.
11. Bali, B., and Kovacs, K. J. (2003). GABAergic control of neuropeptide gene expression in parvocellular neurons of the hypothalamic paraventricular nucleus. Eur. J. Neurosci. 18,1518-1526.
12. Barbaccia, M. L., Roscetti, G., Trabucchi, M., Mostallino, M. C., Concas, A., Purdy, R. H., and Biggio, G. (1996). Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology 63, 166-172.
13. Barbaccia, M. L., Serra, M., Purdy, R. H., and Biggio, G. (2001). Stress and neuroactive steroids. Int. Rev. Neurobiol. 46, 243-272.
14. Barker, D. J. (2002). Fetal programming of coronary heart disease. Trends Endocrinol. Metab. 13,364-368.
15. Barker, J. L., Harrison, N. L., Lange, G. D., and Owen, D. G. (1987). Potentiation of gamma-aminobutyricacid-activated chloride conductance by a steroid anaesthetic in cultured rat spinal neurones. J. Physiol. 386, 485-501.
16. Batarseh, A., and Papadopoulos, V. (2010). Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol. Cell. Endocrinol. 327, 1-12.
17. Belelli, D., Casula, A., Ling, A., and Lambert, J. J. (2002). The influence of subunit composition on the interaction of neurosteroids with GABAA receptors. Neuropharmacology 43, 651-661.
18. Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., and Cope, D. W. (2009). Extrasynaptic GABAA receptors: form, pharmacology, and function. J. Neurosci. 29, 12757-12763.
19. Belelli, D., and Herd, M. B. (2003). The contraceptive agent Provera enhances GABAA receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids? J. Neurosci. 23, 10013-10020.
20. Belelli, D., and Lambert, J. J. (2005). Neurosteroids: endogenous regulators of the GABAA receptor. Nat. Rev. Neurosci. 6, 565-575.
21. Bernardi, F., Lanzone, A., Cento, R. M., Spada, R. S., Pezzani, I., Genazzani, A. D., Luisi, S., Luisi, M., Petraglia, F., and Genazzani, A. R. (2000). Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia. Eur. J. Endocrinol. 142, 466-471.
22. Bianchi, M. T., and Macdonald, R. L. (2003). Neurosteroids shift partial agonist activation of GABAA receptor channels from low- to high-efficacy gating patterns. J. Neurosci. 23,10934-10943.
23. Biggio, G., Concas, A., Follesa, P., Sanna, E., and Serra, M. (2007). Stress, ethanol, and neuroactive steroids. Pharmacol. Ther. 116,140-171.
24. Bitran, D., Shiekh, M., and McLeod, M. (1995). Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J. Neuroendocrinol. 7, 171-177.
25. Blaesse, P., Airaksinen, M. S., Rivera, C., and Kaila, K. (2009). Cation-chloride cotransporters and neuronal function. Neuron 61, 820-838.
26. Bodnoff, S. R., Humphreys, A. G., Lehman, J. C., Diamond, D. M., Rose, G. M., and Meaney, M. J. (1995). Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and midaged rats. J. Neurosci. 15, 61-69.
27. Bortolato, M., Devoto, P., Roncada, P., Frau, R., Flore, G., Saba, P., Pistritto, G., Soggiu, A., Pisanu, S., Zappala, A., Ristaldi, M. S., Tattoli, M., Cuomo, V., Marrosu, E, and Barbaccia, M. L. (2011). Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments. Neuropharmacology 60, 1301-1308.
28. Boudaba, C., Szabo, K., and Tasker, J. G. (1996). Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J. Neurosci. 16,7151-7160.
29. Boyd, K. N., Kumar, S., O'Buckley, T. K., Porcu, P., and Morrow, A. L. (2010). Ethanol induction of steroidogenesis in rat adrenal and brain is dependent upon pituitary ACTH release and de novo adrenal StAR synthesis. J. Neurochem. 112,784-796.
30. Brown, N., Kerby, J., Bonnert, T. P., Whiting, P. J., and Wafford, K. A. (2002). Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors. Br. I Pharmacol. 136, 965-974.
31. Brunton, P. J., McKay, A. J., Ochedalski, T., Piastowska, A., Rebas, E., Lachowicz, A., and Russell, J. A. (2009). Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone. J. Neurosci. 29, 6449-6460.
32. Brunton, P. J., and Russell, J. A. (2008). The expectant brain: adapting for motherhood. Nat. Rev. Neurosci. 9, 11-25.
33. Brunton, P. J., and Russell, J. A. (2010). Prenatal social stress in the rat programmes neuroendocrine and behavioural responses to stress in the adult offspring: sex-specific effects. J. Neuroendocrinol. 22, 258-271.
34. Brunton, P. J., and Russell, J. A. (2011). Neuroendocrine control of maternal stress responses and fetal programming by stress in pregnancy. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1178-1191.
35. Brussaard, A. B., Kits, K. S., Baker, R. E., Willems, W. P., Leyting-Vermeulen, J. W., Voorn, P., Smit, A. B., Bick-nell, R. J., and Herbison, A. E. (1997). Plasticity in fast synaptic inhibition of adult oxytocin neurons caused by switch in GABAA receptor subunit expression. Neuron 19, 1103-1114.
36. Brussaard, A. B., and Koksma, J. J. (2003). Conditional regulation of neurosteroid sensitivity of GABAA receptors. Ann. N Y. Acad. Sci. 1007, 29-36.
37. Caldji, C., Diorio, J., and Meaney, M. J. (2003). Variations in maternal care alter GABAA receptor subunit expression in brain regions associated with fear. Neuropsychopharmacology 28,1950-1959.
38. Callachan, H., Cottrell, G. A., Hather, N. Y., Lambert, J. J., Nooney, J. M., and Peters, J. A. (1987). Modulation of the GABAA receptor by progesterone metabolites. Proc. R. Soc. Lond. B Biol. Sci. 231, 359-369.
39. Carboni, E., Wieland, S., Lan, N. C., and Gee, K. W. (1996). Anxiolytic properties of endogenously occurring pregnanediols in two rodent models of anxiety. Psychopharmacol-ogy (Berl.) 126, 173-178.
40. Carta, M., Mameli, M., and Valen-zuela, C. F. (2004). Alcohol enhances GABAergic transmission to cerebel-lar granule cells via an increase in golgi cell excitability. J. Neurosci. 24, 3746-3751.
41. Chisari, M., Eisenman, L. N., Covey, D. F., Mennerick, S., and Zorumski, C. F. (2010). The sticky issue of neurosteroids and GABAA receptors. Trends Neurosci. 33,299-306.
42. Cole, R. L., and Sawchenko, P. E. (2002). Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventric-ular nucleus of the hypothalamus. J. Neurosci. 22, 959-969.
43. Cooper, E. J., Johnston, G. A., and Edwards, F. A. (1999). Effects of a naturally occurring neurosteroid on GABAA IPSCs during development in rat hippocampal or cere-bellar slices. J. Physiol. 521(Pt 2), 437-449.
44. Corpéchot, C., Young, J., Calvel, M., Wehrey, C., Veltz, J. N., Touyer, G., Mouren, M., Prasad, V. V., Banner, C., and Sjovall, J. (1993). Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroido-genic glands of male and female rats. Endocrinology 133, 1003-1009.
45. Crawley, J. N., Glowa, J. R., Majewska, M. D., and Paul, S. M. (1986). Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398, 382-385.
46. Crossley, K. J., Walker, D. W., Beart, P. M., and Hirst, J. J. (2000). Characterisation of GABAA receptors in fetal, neonatal and adult ovine brain: region and age related changes and the effects of allopregnanolone. Neuropharmacology 39, 1514-1522.
47. Cullinan, W. E. (2000). GABAA receptor subunit expression within hypophysiotropic CRH neurons: a dual hybridization histochemical study. J. Comp. Neurol. 419, 344-351.
48. Cullinan, W. E., and Wolfe, T. J. (2000). Chronic stress regulates levels of mRNA transcripts encoding beta subunits of the GABAA receptor in the rat stress axis. Brain Res. 887, 118-124.
49. Cullinan, W E., Ziegler, D. R., and Herman, J. P. (2008). Functional role of local GABAergic influences on the HPA axis. Brain Struct. Funct. 213, 63-72.
50. Cunningham, E. T. Jr., and Sawchenko, P. E. (1988). Anatomical specificity of noradrenergic inputs to the par-aventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 274, 60-76.
51. Curley, J. P., Jensen, C. L., Mashoodh, R., and Champagne, F. A. (2011). Social influences on neurobiology and behavior: epigenetic effects during development. Psychoneuroendocrinology 36, 352-371.
52. Daftary, S. S., Boudaba, C., and Tasker, J. G. (2000). Noradrenergic regulation of parvocellular neurons in the rat hypothalamic paraventricular nucleus. Neuroscience 96, 743-751.
53. de Kloet, E. R., Joels, M., and Holsboer, F. (2005). Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6,463-475.
54. Di, S., Malcher-Lopes, R., Halmos, K. C., and Tasker, J. G. (2003). Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 23, 4850-4857.
55. Di, S., Malcher-Lopes, R., Marcheselli, V. L., Bazan, N. G., and Tasker, J. G. (2005). Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocel-lular neurons. Endocrinology 146, 4292-4301.
56. Di, S., Maxson, M. M., Franco, A., and Tasker, J. G. (2009). Glucocorti-coids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J. Neurosci. 29, 393-401.
57. Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M. C., Pelletier, G., and Vaudry, H. (2009). Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front. Neuroendocrinol. 30,259-301.
58. Dzhala, V. I., Talos, D. M., Sdrulla, D. A., Brumback, A. C., Mathews, G. C., Benke, T. A., Delpire, E., Jensen, F. E., and Staley, K. J. (2005). NKCC1 transporter facilitates seizures in the developing brain. Nat. Med. 11, 1205-1213.
59. Eechaute, W. P., Dhooge, W S., Gao, C. Q., Calders, P., Rubens, R., Weyne, J., and Kaufman, J. M. (1999). Progesterone-transforming enzyme activity in the hypothalamus of the male rat. J. Steroid Biochem. Mol. Biol. 70,159-167.
60. Ehrlich, I., Humeau, Y., Grenier, F., Cioc-chi, S., Herry, C., and Luthi, A. (2009). Amygdala inhibitory circuits and the control of fear memory. Neuron 62, 757-771.
61. Engelmann, M., Landgraf, R., and Wot-jak, C. T. (2004). The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front. Neuroendocrinol. 25, 132-149.
62. Enoch, M. A., Hodgkinson, C. A., Yuan, Q., Shen, P. H., Goldman, D., and Roy, A. (2010). The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence. Biol. Psychiatry 67, 20-27.
63. Eser, D., di Michele, F., Zwanzger, P., Pasini, A., Baghai, T. C., Schüle, C., Rupprecht, R., and Romeo, E. (2005). Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3α,5α tetrahydrodeoxycorticosterone (3α, 5α-THDOC) in healthy volunteers. Neuropsychopharmacology 30, 192-195.
64. Eser, D., Romeo, E., Baghai, T. C., di Michele, F., Schule, C., Pasini, A., Zwanzger, P., Padberg, F., and Rupprecht, R. (2006). Neuroactive steroids as modulators of depression and anxiety. Neuroscience 138, 1041-1048.
65. Fancsik, A., Linn, D. M., and Tasker, J. G. (2000). Neurosteroid modulation of GABA IPSCs is phospho-rylation dependent. J. Neurosci. 20, 3067-3075.
66. Farrant, M., and Nusser, Z. (2005). Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors. Nat. Rev. Neurosci. 6, 215-229.
67. Fenoglio, K. A., Brunson, K. L., Avishai-Eliner, S., Stone, B. A., Kapadia, B. J., and Baram, T. Z. (2005). Enduring, handling-evoked enhancement of hippocampal memory function and glucocorticoid receptor expression involves activation of the corticotropin-releasing factor type 1 receptor. Endocrinology 146, 4090-4096.
68. Flak, J. N., Ostrander, M. M., Tasker, J. G., and Herman, J. P. (2009). Chronic stress-induced neurotransmitter plasticity in the PVN. J. Comp. Neurol. 517, 156-165.
69. Ford, M. M., Nickel, J. D., Phillips, T. J., and Finn, D. A. (2005). Neurosteroid modulators of GABAA receptors differentially modulate ethanol intake patterns in male C57BL/6J mice. Alcohol. Clin. Exp. Res. 29, 1630-1640.
70. Francis, D., Diorio, J., Liu, D., and Meaney, M. J. (1999). Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286, 1155-1158.
71. Francis, D. D., and Meaney, M. J. (1999). Maternal care and the development of stress responses. Curr. Opin. Neu-robiol. 9, 128-134.
72. Fritschy, J. M., and Brunig, I. (2003). Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol. Ther. 98, 299-323.
73. Fritschy, J. M., and Mohler, H. (1995). GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359,154-194.
74. Gallagher, J. P., Orozco-Cabal, L. F., Liu, J., and Shinnick-Gallagher, P. (2008). Synaptic physiology of central CRH system. Eur. J. Pharmacol. 583,215-225.
75. Gao, C. Q., Dhooge, W. S., Kaufman, J. M., Weyne, J. J., and Eechaute, W. P. (2002). Hypothalamic 5α-reductase and 3α-oxidoreductase activity in the male rat. J. Steroid Biochem. Mol. Biol. 80,91-98.
76. Gasior, M., Carter, R. B., and Witkin, J. M. (1999). Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol. Sci. 20, 107-112.
77. Gee, K. W., Bolger, M. B., Brinton, R. E., Coirini, H., and McEwen, B. S. (1988). Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 246, 803-812.
78. Gee, K. W., Chang, W. C., Brinton, R. E., and McEwen, B. S. (1987). GABA-dependent modulation of the Clionophore by steroids in rat brain. Eur. I Pharmacol. 136, 419-423.
79. Goldwater, D. S., Pavlides, C., Hunter, R. G., Bloss, E. B., Hof, P. R., McEwen, B. S., and Morrison, J. H. (2009). Structural and functional alterations to rat medial prefrontal cortex following chronic restraint stress and recovery. Neuroscience 164, 798-808.
80. Griffin, L. D., and Mellon, S. H. (1999). Selective serotonin reup-take inhibitors directly alter activity of neurosteroidogenic enzymes. Proc. Natl. Acad. Sci. U.S.A. 96, 13512-13517.
81. Grobin, A. C., Heenan, E. J., Lieber-man, J.A.,and Morrow, A. L. (2003). Perinatal neurosteroid levels influence GABAergic interneuron localization in adult rat prefrontal cortex. J. Neurosci. 23, 1832-1839.
82. Guidotti, A., and Costa, E. (1998). Can the antidysphoric and anxi-olytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3α, 5α-tetrahydroprogesterone (allo-pregnanolone) availability? Biol. Psychiatry 44, 865-873.
83. Gunn, B. G., Cooper, M. A., Lambert, J. J., and Belelli, D. B. (2010). Neurosteroids Potently Enhance Synaptic GABAA Receptor-Mediated Inhibition in Medial Parvocellular Neurons of the Paraventricular Nucleus of the Mouse Hypothalamus. Program No. 338.26. 2010. Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience.
84. Haage, D., Druzin, M., and Johansson, S. (2002). Allopregnanolone modulates spontaneous GABA release via presynaptic Cl- permeability in rat preoptic nerve terminals. Brain Res. 958,405-413.
85. Han, S. K., Chong, W., Li, L. H., Lee, I. S., Murase, K., and Ryu, P. D. (2002). Noradrenaline excites and inhibits GABAergic transmission in parvocellular neurons of rat hypo-thalamic paraventricular nucleus. J. Neurophysiol. 87,2287-2296.
86. Harney, S. C., Frenguelli, B. G., and Lambert, J. J. (2003). Phosphorylation influences neurosteroid modulation of synaptic GABAA receptors in rat CA1 and dentate gyrus neurones. Neuropharmacology 45, 873-883.
87. Harrison, N. L., and Simmonds, M. A. (1984). Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 323, 287-292.
88. Harrison, N. L., Vicini, S., and Barker, J. L. (1987). A steroid anesthetic prolongs inhibitory postsynaptic currents in cultured rat hippocampal neurons. J. Neurosci. 7, 604-609.
89. Heilig, M., and Koob, G. F. (2007). A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 30, 399-406.
90. Herd, M. B., Belelli, D., and Lambert, J. J. (2007). Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors. Pharmacol. Ther. 116,20-34.
91. Herman, J. P., and Cullinan, W. E. (1997). Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20, 78-84.
92. Herman, J. P., Cullinan, W. E., Ziegler, D. R., and Tasker, J. G. (2002). Role of the paraventricular nucleus microenvironment in stress integration. Eur. J. Neurosci. 16, 381-385.
93. Herman, J. P., Figueiredo, H., Mueller, N. K., Ulrich-Lai, Y., Ostrander, M. M., Choi, D. C., and Cullinan, W. E. (2003). Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front. Neuroendocrinol. 24, 151-180.
94. Hewitt, S. A., Wamsteeker, J. I., Kurz, E. U., and Bains, J. S. (2009). Altered chloride homeosta-sis removes synaptic inhibitory constraint of the stress axis. Nat. Neurosci. 12,438-443.
95. Hirst, J. J., Walker, D. W., Yawno, T., and Palliser, H. K. (2009). Stress in pregnancy: a role for neuroactive steroids in protecting the fetal and neonatal brain. Dev. Neurosci. 31, 363-377.
96. Hodge, C. W., Mehmert, K. K., Kel-ley, S. P., McMahon, T., Haywood, A., Olive, M. F., Wang, D., Sanchez-Perez, A. M., and Messing, R. O. (1999). Supersensitivity to allosteric GABAA receptor modulators and alcohol in mice lacking PKCε. Nat. Neurosci. 2, 997-1002.
97. Holsboer, E (2000). The corticos-teroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477-501.
98. Hosie, A. M., Clarke, L., da Silva, H., and Smart, T. G. (2009). Conserved site for neurosteroid modulation of GABAA receptors. Neuropharmacology 56, 149-154.
99. A receptors through two discrete transmembrane sites. Nature 444, 486-489.
100. Imaki, T., Nahan, J. L., Rivier, C., Sawchenko, P. E., and Vale, W. (1991). Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glu-cocorticoids and stress. J. Neurosci. 11,585-599.
101. Izumi, Y., Murayama, K., Tokuda, K., Krishnan, K., Covey, D. F., and Zorumski, C. E (2007). GABAergic neurosteroids mediate the effects of ethanol on long-term potentia-tion in rat hippocampal slices. Eur. J. Neurosci. 26, 1881-1888.
102. Izumi, Y., Tokuda, K., and Zorumski, C. E (2008). Long-term poten-tiation inhibition by low-level N-methyl-d-aspartate receptor activation involves calcineurin, nitric oxide, and p38 mitogen-activated protein kinase. Hippocampus 18, 258-265.
103. Joels, M., Karst, H., Krugers, H. J., and Lucassen, P. J. (2007). Chronic stress: implications for neuronal morphology, function and neuro-genesis. Front. Neuroendocrinol. 28, 72-96.
104. Karavolas, H. J., and Hodges, D. R. (1990). Neuroendocrine metabolism of progesterone and related progestins. Ciba Found. Symp. 153, 22-44.
105. Karst, H., Berger, S., Erdmann, G., Schutz, G., and Joels, M. (2010). Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc. Natl. Acad. Sci. U.S.A. 107, 14449-14454.
106. Karst, H., Berger, S., Turiault, M., Tronche, F., Schutz, G., and Joels, M. (2005). Mineralocorticoidreceptors are indispensable for nonge-nomic modulation of hippocampal glutamate transmission by corticosterone. Proc. Natl. Acad. Sci. U.S.A. 102,19204-19207.
107. Kehoe, P., Mallinson, K., McCormick, C. M., and Frye, C. A. (2000). Central allopregnanolone is increased in rat pups in response to repeated, short episodes of neonatal isolation. Brain Res. Dev. Brain Res. 124,133-136.
108. Keller, E. A., Zamparini, A., Borodinsky, L. N., Gravielle, M. C., and Fisz-man, M. L. (2004). Role of allopregnanolone on cerebellar granule cells neurogenesis. Brain Res. Dev. Brain Res. 153, 13-17.
109. Khisti, R. T., Boyd, K. N., Kumar, S., and Morrow, A. L. (2005). Systemic ethanol administration elevates deoxycorticosterone levels and chronic ethanol exposure attenuates this response. Brain Res. 1049, 104-111.
110. Khisti, R. T., VanDoren, M. J., O'Buckley, T., and Morrow, A. L. (2003). Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates ethanol-induced loss of righting reflex in rats. Brain Res. 980, 255-265.
111. Kittler, J. T., and Moss, S. J. (2003). Modulation of GABAA receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Curr. Opin. Neurobiol. 13,341-347.
112. Koksma, J. J., Van Kesteren, R. E., Rosahl, T. W., Zwart, R., Smit, A. B., Luddens, H., and Brussaard, A. B. (2003). Oxytocin regulates neurosteroid modulation of GABAA receptors in supraoptic nucleus around parturition. J. Neurosci. 23,788-797.
113. Koob, G., andKreek, M. J. (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am. J. Psychiatry 164, 1149-1159.
114. Koob, G. E (2008). A role for brain stress systems in addiction. Neuron 59,11-34.
115. Koob, G. F., and Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24, 97-129.
116. Koob, G. F., and Zorrilla, E. P. (2010). Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr. Opin. Investig. Drugs 11,63-71.
117. Korosi, A., Shanabrough, M., McClel-land, S., Liu, Z. W., Borok, E., Gao, X. B., Horvath, T. L., and Baram, T. Z. (2010). Early-life experience reduces excitation to stress-responsive hypothalamic neurons and reprograms the expression of corticotropin-releasing hormone. J. Neurosci. 30, 703-713.
118. Kullmann, D. M., Ruiz, A., Rusakov, D. M., Scott, R., Semyanov, A., and Walker, M. C. (2005). Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? Prog. Biophys. Mol. Biol. 87, 33-46.
119. Lambert, J. J., Belelli, D., Hill-Venning, C., and Peters, J. A. (1995). Neurosteroids and GABAA receptor function. Trends Pharmacol. Sci. 16, 295-303.
120. Lambert, J. J., Cooper, M. A., Simmons, R. D., Weir, C. J., and Belelli, D. (2009). Neurosteroids: endogenous allosteric modulators of GABAA receptors. Psychoneuroendocrinology 34(Suppl. 1), S48-S58.
121. Lambert, J. J., Peters, J. A., and Cot-trell, G. A. (1987). Actions of synthetic and endogenous steroids on the GABAA receptor. Trends Pharmacol. Sci. 8, 224-227.
122. Levitt, N. S., Lambert, E. V., Woods, D., Hales, C. N., Andrew, R., and Seckl, J. R. (2000). Impaired glucose tolerance and elevated blood pressure in low birth weight, non obese, young south african adults: early programming of cortisol axis. J. Clin. Endocrinol Metab. 85, 4611-4618.
123. Li, X., Bertics, P. J., and Karavolas, H. J. (1997). Regional distribution of cytosolic and partic-ulate 5α-dihydroprogesterone 3α-hydroxysteroid oxidoreductases in female rat brain. J. Steroid Biochem. Mol. Biol. 60,311-318.
124. Liston, C., Miller, M. M., Goldwater, D. S., Radley, J. J., Rocher, A. B., Hof, P. R., Morrison, J. H., and McEwen, B. S. (2006). Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual atten-tional set-shifting. J. Neurosci. 26, 7870-7874.
125. Longone, P., Rupprecht, R., Manieri, G. A., Bernardi, G., Romeo, E., and Pasini, A. (2008). The complex roles of neurosteroids in depression and anxiety disorders. Neurochem. Int. 52, 596-601.
126. Luchetti, S., Huitinga, I., and Swaab, D. E (2011). Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience 191, 6-21.
127. Ludwig, M., and Leng, G. (2006). Dendritic peptide release and peptide-dependent behaviours. Nat. Rev. Neurosci. 7, 126-136.
128. Lupien, S. J., McEwen, B. S., Gunnar, M. R., and Heim, C. (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 10,434-445.
129. Magarinos, A. M., and McEwen, B. S. (1995). Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glu-cocorticoid secretion and excitatory amino acid receptors. Neuroscience 69,89-98.
130. Maguire, J., and Mody, I. (2007). Neurosteroid synthesis-mediated regulation of GABAA receptors: relevance to the ovarian cycle and stress. J. Neurosci. 27, 2155-2162.
131. Maguire, J., and Mody, I. (2008). GABAAR plasticity during pregnancy: relevance to postpartum depression. Neuron 59,207-213.
132. Maguire, J., and Mody, I. (2009). Steroid hormone fluctuations and GABAAR plasticity. Psychoneuroendocrinology 34(Suppl. 1), S84-S90.
133. Makino, S., Gold, P. W., and Schulkin, J. (1994). Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellu-lar region of the paraventricular nucleus of the hypothalamus. Brain Res. 640, 105-112.
134. Matsumoto, K., Uzunova, V., Pinna, G., Taki, K., Uzunov, D. P., Watan-abe, H., Mienville, J. M., Guidotti, A., and Costa, E. (1999). Permissive role of brain allopreg-nanolone content in the regulation of pentobarbital-induced righting reflex loss. Neuropharmacology 38, 955-963.
135. McEwen, B. S. (2003). Early life influences on life-long patterns of behaviour and health. Ment. Retard Dev. Disabil Res. Rev. 9, 149-154.
136. McEwen, B. S. (2010). Stress, sex, and neural adaptation to a changing environment: mechanisms of neu-ronal remodeling. Ann. N Y. Acad. Sci. 1204(Suppl.), E38-E59.
137. McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonte, B., Szyf, M., Turecki, G., and Meaney, M. J. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342-348.
138. Meaney, M. J., Viau, V., Bhatnagar, S., Betito, K., Iny, L. J., O'Donnell, D., and Mitchell, J. B. (1991). Cellular mechanisms underlying the development and expression of individual differences in the hypothalamic-pituitary-adrenal stress response. J. Steroid Biochem. Mol. Biol. 39, 265-274.
139. Melcangi, R. C., Celotti, F., Castano, P., and Martini, L. (1993). Differential localisation of the 5α-reductase and the 3α-hydroxysteroid dehy-drogenase in neuronal and glial cell cultures. Endocrinology 132, 1252-1259.
140. Mellon, S. H. (2004). "Synthesis, enzymes localizations and regulation of neurosteroids," in Neurosteroid Effects in the Central Nervous System: The Role of the GABAAR. Methods andNew Frontiers in Neuroscience, ed. S. S. Smith (Boca Raton: CRC Press), 1-46.
141. Mellon, S. H., and Griffin, L. D. (2002). Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13,35-43.
142. Mellon, S. H., and Vaudry, H. (2001). Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46, 33-78.
143. Mennerick, S., He, Y., Jiang, X., Man-ion, B. D., Wang, M., Shute, A., Benz, A., Evers, A. S., Covey, D. F., andZorumski, C. E (2004). Selective antagonism of 5α-reduced neurosteroid effects at GABAA receptors. Mol. Pharmacol. 65,1191-1197.
144. Mihalek, R. M., Banerjee, P. K., Korpi, E. R., Quinlan, J. J., Firestone, L. L., Mi, Z. P., Lagenaur, C., Tretter, V., Sieghart, W., Anagnostaras, S. G., Sage, J. R., Fanselow, M. S., Guidotti, A., Spigelman, I., Li, Z., DeLorey, T. M., Olsen, R. W., and Homan-ics, G. E. (1999). Attenuated sensitivity to neuroactive steroids in γ-aminobutyrate type A receptor delta subunit knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96, 12905-12910.
145. Miklos, I. H., and Kovacs, K. J. (2002). GABAergic innervation of corticotropin-releasing hormone (CRH)-secreting parvocellular neurons and its plasticity as demonstrated by quantitative immunoelectron microscopy. Neuroscience 113, 581-592.
146. Mitev, Y. A., Darwish, M., Wolf, S. S., Holsboer, F., Almeida, O. F., and Patchev, V. K. (2003). Gender differences in the regulation of 3α-hydroxysteroid dehydrogenase in rat brain and sensitivity to neurosteroid-mediated stress protection. Neuroscience 120, 541-549.
147. Mitra, R., and Sapolsky, R. M. (2008). Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 105, 5573-5578.
148. Molina-Hernandez, M., Tellez-Alcantara, N. P., Garcia, J. P., Lopez, J. I., and Jaramillo, M. T. (2005). Antidepressant-like actions of intra-accumbens infusions of allopregnanolone in ovariectomized Wistar rats. Pharmacol. Biochem. Behav. 80,401-409.
149. Morrow, A. L., Porcu, P., Boyd, K. N., and Grant, K. A. (2006). Hypothalamic-pituitary-adrenal axis modulation of GABAergic neuroactive steroids influences ethanol sensitivity and drinking behavior. Dialogues Clin. Neurosci. 8, 463-477.
150. Morrow, A. L., VanDoren, M. J., Pen-land, S. N., and Matthews, D. B. (2001). The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res. Brain Res. Rev. 37, 98-109.
151. Motzo, C., Porceddu, M. L., Maira, G., Flore, G., Concas, A., Dazzi, L., and Biggio, G. (1996). Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone. J. Psychopharmacol. 10,266-272.
152. Murgatroyd, C., Patchev, A. V., Wu, Y., Micale, V., Bockmuhl, Y., Fischer, D., Holsboer, F., Wotjak, C. T., Almeida, O. F., and Spengler, D. (2009). Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat. Neurosci. 12, 1559-1566.
153. Neigh, G. N., Gillespie, C. F., and Nemeroff, C. B. (2009). The neu-robiological toll of child abuse and neglect. Trauma Violence Abuse 10, 389-410.
154. Nguyen, P. N., Billiards, S. S., Walker, D. W., and Hirst, J. J. (2003). Changes in 5α-pregnane steroids and neu-rosteroidogenic enzyme expression in fetal sheep with umbilicoplacen-tal embolization. Pediatr. Res. 54, 840-847.
155. Nguyen, P. N., Yan, E. B., Castillo-Melendez, M., Walker, D. W., and Hirst, J. J. (2004). Increased allopregnanolone levels in the fetal sheep brain following umbilical cord occlusion. J. Physiol. (Lond.) 560, 593-602.
156. Nie, Z., Schweitzer, P., Roberts, A. J., Madamba, S. G., Moore, S. D., and Siggins, G. R. (2004). Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 303, 1512-1514.
157. Nusser, Z., Sieghart, W., and Somogyi, P. (1998). Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cere-bellar granule cells. J. Neurosci. 18, 1693-1703.
158. Olsen, R. W., and Sieghart, W. (2008). International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of sub-unit composition, pharmacology, and function. Update. Pharmacol. Rev. 60, 243-260.
159. A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56, 141-148.
160. Orchinik, M., Weiland, N. G., and McEwen, B.S. (1995). Chronic exposure to stress levels of corticosterone alters GABAA receptor sub-unit mRNA levels in rat hippocampus. Brain Res. Mol. Brain Res. 34, 29-37.
161. Owens, M. J., and Nemeroff, C. B. (1991). Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43,425-473.
162. Padberg, F., di Michele, F., Zwanzger, P., Romeo, E., Bernardi, G., Schule, C., Baghai, T. C., Ella, R., Pasini, A., and Rupprecht, R. (2002). Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Neuropsychopharmacology 27, 874-878.
163. Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapere, J. J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M. R., and Gavish, M. (2006). Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402-409.
164. Patchev, V. K., Hassan, A. H., Holsboer, D. F., and Almeida, O. E (1996). The neurosteroid tetrahy- droprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcrip tion in the rat hypothalamus. Neuropsychopharmacology 15, 533-540.
165. Patchev, V. K., Montkowski, A., Rouskova, D., Koranyi, L., Holsboer, E, and Almeida, O. E (1997). Neonatal treatment of rats with the neuroactive steroid tetrahy-drodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. J. Clin. Invest. 99, 962-966.
166. Patchev, V. K., Shoaib, M., Holsboer, E, and Almeida, O. E (1994). The neurosteroid tetrahydroprog-esterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypo-thalamus. Neuroscience 62,265-271
167. Paul, S. M., and Purdy, R. H. (1992). Neuroactive steroids. FASEB J. 6, 2311-2322.
168. A receptor by depressant barbiturates and pregnane steroids. Br. J. Pharmacol. 94, 1257-1269.
169. Pinna, G. (2010). In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allo-pregnanolone biosynthesis. Behav. Pharmacol. 21,438-450.
170. Pinna, G., Costa, E., and Guidotti, A. (2004). Fluoxetine and norfluoxe-tine stereospecifically facilitate pen-tobarbital sedation by increasing neurosteroids. Proc. Natl. Acad. Sci. U.S.A. 101, 6222-6225.
171. Pinna, G., Costa, E., and Guidotti, A. (2009). SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr. Opin. Pharmacol. 9, 24-30.
172. Plotsky, P. M., and Meaney, M. J. (1993). Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Brain Res. Mol. Brain Res. 18, 195-200.
173. Puia, G., Mienville, J. M., Matsumoto, K., Takahata, H., Watanabe, H., Costa, E., and Guidotti, A. (2003). On the putative physiological role of allopregnanolone on GABAA receptor function. Neuropharmacology 44, 49-55.
174. Purdy, R. H., Morrow, A. L., Moore, P. H. Jr., and Paul, S. M. (1991). Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. U.S.A. 88, 4553-4557.
175. Radley, J. J., Rocher, A. B., Janssen, W. G., Hof, P. R., McEwen, B. S., and Morrison, J. H. (2005). Reversibility of apical dendritic retraction in the rat medial prefrontal cortex following repeated stress. Exp. Neurol. 196, 199-203.
176. Radley, J. J., Rocher, A. B., Rodriguez, A., Ehlenberger, D. B., Dammann, M., McEwen, B. S., Morrison, J. H., Wearne, S. L., and Hof, P. R. (2008). Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex. J. Comp. Neurol. 507, 1141-1150.
177. Rasmussen, D. D., Boldt, B. M., Bryant, C. A., Mitton, D. R., Larsen, S. A., and Wilkinson, C. W. (2000). Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol. Clin. Exp. Res. 24, 1836-1849.
178. Reddy, D. S. (2006). Physiological role of adrenal deoxycorticosterone-derived neuroactive steroids in stress-sensitive conditions. Neuroscience 138,911-920.
179. Reddy, D. S., and Jian, K. (2010). The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors. J. Pharmacol. Exp. Ther. 334, 1031-1041.
180. Reddy, D. S., and Rogawski, M. A. (2002). Stress-induced deoxycorticosterone-derived neurosteroids modulate GABAA receptor function and seizure susceptibility. J. Neurosci. 22, 3795-3805.
181. Repetti, R. L., Taylor, S. E., and Seeman, T. E. (2002). Risky families: family social environments and the mental and physical health of offspring. Psychol. Bull. 128, 330-366.
182. Represa, A., and Ben-Ari, Y. (2005). Trophic actions of GABA on neu-ronal development. Trends Neurosci. 28,278-283.
183. A receptors in aging and Alzheimer's disease. J. Neurochem. 103, 1285-1292.
184. Roberto, M., Madamba, S. G., Moore, S. D., Tallent, M. K., and Siggins, G. R. (2003). Ethanol increases GABAer-gic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc. Natl. Acad. Sci. U.S.A. 100,2053-2058.
185. Romeo, E., Strohle, A., Spalletta, G., di Michele, F., Hermann, B., Holsboer, F., Pasini, A., and Rupprecht, R. (1998). Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry 155,910-913.
186. Roozendaal, B., McEwen, B. S., and Chattarji, S. (2009). Stress, memory and the amygdala. Nat. Rev. Neurosci. 10,423-433.
187. Rouge-Pont, F., Mayo, W., Marinelli, M., Gingras, M., Le Moal, M., and Piazza, P. V. (2002). The neurosteroid allopregnanolone increases dopamine release and dopaminer-gic response to morphine in the rat nucleus accumbens. Eur. J. Neurosci. 16, 169-173.
188. A receptors enhance transmission and LTP induction at hippocampal mossy fiber synapses. Nat. Neurosci. 13, 431-438.
189. Rupprecht, R. (2003). Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28, 139-168.
190. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., and Schumacher, M. (2010). Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 9, 971-988.
191. Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schule, C., Noth-durfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, E, Uzunov, V., McAllister, K. H., Bertaina-Anglade, V., La Rochelle, C. D., Tuerck, D., Floesser, A., Kiese, B., Schumacher, M., Land-graf, R., Holsboer, F., and Kucher, K. (2009). Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325, 490-493.
192. Saalmann, Y. B., Kirkcaldie, M. T., Waldron, S., and Calford, M. B. (2007). Cellular distribution of the GABAA receptor-modulating 3α-hydroxy, 5α-reduced pregnane steroids in the adult rat brain. J. Neuroendocrinol. 19,272-284.
193. Sanchez, M. M., Ladd, C. O., and Plot-sky, P. M. (2001). Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Dev. Psychopathol. 13, 419-449.
194. Sánchez, P., Torres, J. M., Gavete, P., and Ortega, E. (2008). Effects of swim stress on mRNA and protein levels of steroid 5α-reductase isozymes in adult rat brain. Neurochem. Int. 52, 426-431.
195. Sanna, E., Cuccheddu, T., Serra, M., Concas, A., and Biggio, G. (1992). Carbon dioxide inhalation reduces the function of GABAA receptors in the rat brain. Eur. J. Pharmacol. 216, 457-458.
196. Sanna, E., Talani, G., Busonero, F., Pisu, M. G., Purdy, R. H., Serra, M., and Biggio, G. (2004). Brain steroido-genesis mediates ethanol modulation of GABAA receptor activity in rat hippocampus. J. Neurosci. 24, 6521-6530.
197. Sapolsky, R. M., and Meaney, M. J. (1986). Maturation of the adreno-cortical stress response: neuroen-docrine control mechanisms and the stress hyporesponsive period. Brain Res. 396, 64-76.
198. Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., and Sturm, V. (2008). Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacol-ogy 33, 368-377.
199. Schule, C., Baghai, T. C., Eser, D., and Rupprecht, R. (2009). Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression. Expert Rev. Neurother. 9, 1005-1019.
200. Schule, C., di Michele, F., Baghai, T., Romeo, E., Bernardi, G., Zwanzger, P., Padberg, F., Pasini, A., and Rupprecht, R. (2003). Influence of sleep deprivation on neuroactive steroids in major depression. Neu-ropsychopharmacology 28, 577-581.
201. Schule, C., Romeo, E., Uzunov, D. P., Eser, D., di Michele, F., Baghai, T. C., Pasini, A., Schwarz, M., Kempter, H., and Rupprecht, R. (2006). Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydro-genase activity. Mol. Psychiatry 11, 261-272.
202. Selye, H. (1941). Anaesthetic effects of steroid hormones. Proc. Soc. Exp. Biol.Med.46, 116-121.
203. Semba, J., Wakuta, M., Maeda, J., and Suhara, T. (2004). Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation. Psychoneuroendocrinology 29,215-226.
204. Serra, M., Pisu, M. G., Littera, M., Papi, G., Sanna, E., Tuveri, F., Usala, L., Purdy, R. H., and Biggio, G. (2000). Social isolation-induced decreases in both the abundance of neuroactive steroids and GABAA receptor function in rat brain. J. Neurochem. 75, 732-740.
205. Serra, M., Pisu, M. G., Mostallino, M. C., Sanna, E., and Biggio, G. (2008). Changes in neuroactive steroid content during social isolation stress modulate GABAA receptor plasticity and function. Brain Res. Rev. 57, 520-530
206. Serra, M., Pisu, M. G., Muggironi, M., Parodo, V., Papi, G., Sari, R., Dazzi, L., Spiga, F., Purdy, R. H., and Biggio, G. (2001). Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain. Psychopharmacol-ogy(Berl.) 158, 48-54.
207. Shen, H., Sabaliauskas, N., Sherpa, A., Fenton, A. A., Stelzer, A., Aoki, C., andSmith, S.S. (2010).Acriticalrole for α4βδ GABAA receptors in shaping learning defeci8ts at puberty in mice. Science 327,1515-1518.
208. Sierra, A. (2004). Neurosteroids: the StAR protein in the brain. J. Neu-roendocrinol. 16, 787-793.
209. Singh, C., Liu, L., Wang, J. M., Irwin, R. W., Yao, J., Chen, S., Henry, S., Thompson, R. F., and Brinton, R. D. (2011). Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice. Neurobiol.Aging. doi: 10.1016/j.neurobiolaging.2011.06. 008
210. Smith, S. S., Ruderman, Y., Frye, C., Homanics, G., and Yuan, M. (2006). Steroid withdrawal in the mouse results in anxiogenic effects of 3α, 5β-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology (Berl.) 186, 323-333.
211. Sotiropoulos, I., Catania, C., Pinto, L. G., Silva, R., Pollerberg, G. E., Takashima, A., Sousa, N., and Almeida, O. F. (2011). Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits. J. Neurosci. 31,7840-7847.
212. Sundstrom-Poromaa, I. (2004). "Premenstrual dysphoric disorder," in Neurosteroid Effects in the Central Nervous System, ed. S. S. Smith (Boca Raton: CRC Press), 291-304.
213. Swanson, L. W., Sawchenko, P. E., Rivier, J., and Vale, W. W. (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neu-roendocrinology 36, 165-186.
214. Swanson, L. W., and Simmons, D. M. (1989). Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J. Comp. Neurol. 285,413-435.
215. Szabadics, J., Varga, C., Molnar, G., Olah, S., Barzo, P., and Tamas, G. (2006). Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits. Science 311, 233-235.
216. Tasker, J. G., and Herman, J. P. (2011). Mechanisms of rapid glu-cocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis. Stress 14, 398-406.
217. Tokuda, K., Izumi, Y., and Zorum-ski, C. F. (2011). Ethanol enhances neurosteroidogenesis in hippocam-pal pyramidal neurons by paradoxical NMDA receptor activation. J. Neurosci. 31,9905-9909.
218. Tokuda, K., O'Dell, K. A., Izumi, Y., andZorumski, C. F. (2010).Midazo-lam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodi-azepine receptor activation and neurosteroidogenesis. J. Neurosci. 30, 16788-16795.
219. Torres, J. M., Ruiz, E., and Ortega, E. (2001). Effects of CRH and ACTH administration on plasma and brain neurosteroid levels. Neurochem. Res. 26, 555-558.
220. Trauger, J. W., Jiang, A., Stearns, B. A., and LoGrasso, P. V. (2002). Kinetics of allopregnanolone formation catalyzed by human 3α-hydroxysteroid dehydrogenase type III (AKR1C2). Biochemistry 41, 13451-13459.
221. Trigo, F. F., Marty, A., and Stell, B. M. (2008). Axonal GABAA receptors. Eur. J. Neurosci. 28, 841-848.
222. Tsankova, N., Renthal, W., Kumar, A., and Nestler, E. J. (2007). Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8, 355-367.
223. Tsutsui, K. (2008). Neurosteroids in the Purkinje cell: biosynthesis, mode of action and functional significance. Mol. Neurobiol. 37, 116-125.
224. Uchida, S., Noda, E., Kakazu, Y., Mizoguchi, Y., Akaike, N., and Nabekura, J. (2002). Allopregnanolone enhancement of GABAergic transmission in rat medial preoptic area neurons. Am. J. Physiol. Endocrinol. Metab. 283, E1257-E1265.
225. Ulrich-Lai, Y M., and Herman, J. P. (2009). Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 10, 397-409.
226. Uzunov, D. P., Cooper, T. B., Costa, E., and Guidotti, A. (1996). Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc. Natl. Acad. Sci. U.S.A. 93, 12599-12604.
227. Uzunova, V., Sampson, L., and Uzunov, D. P. (2006). Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl.) 186,351-361.
228. Uzunova, V., Sheline, Y., Davis, J. M., Rasmusson, A., Uzunov, D. P., Costa, E., and Guidotti, A. (1998). Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxam-ine. Proc. Natl. Acad. Sci. U.S.A. 95, 3239-3244.
229. Vale, W., Spiess, J., Rivier, C., and Rivier, J. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of cor-ticotropin and beta-endorphin. Science 213, 1394-1397.
230. VanDoren, M. J., Matthews, D. B., Janis, G. C., Grobin, A. C., Devaud, L. L., and Morrow, A. L. (2000). Neuroactive steroid 3α-hydroxy- 5α-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J. Neurosci. 20, 1982-1989.
231. Verkuyl, J. M., Hemby, S. E., and Joels, M. (2004). Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. Eur. J. Neurosci. 20, 1665-1673.
232. Verleye, M., Akwa, Y., Liere, P., Ladurelle, N., Pianos, A., Eychenne, B., Schumacher, M., and Gillardin, J. M. (2005). The anxiolytic etifoxine activates the peripheral benzodi-azepine receptor and increases the neurosteroid levels in rat brain. Pharmacol. Biochem. Behav. 82, 712-720.
233. Wang, J. M., Johnston, P. B., Ball, B. G., and Brinton, R. D. (2005). The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J. Neurosci. 25, 4706-4718.
234. Wang, J. M., Liu, L., Irwin, R. W., Chen, S., and Brinton, R. D. (2008). Regenerative potential of allopregnanolone. Brain Res. Rev. 57, 398-409.
235. Wang, J. M., Singh, C., Liu, L., Irwin, R. W., Chen, S., Chung, E. J., Thompson, R. F., and Brinton, R. D. (2010). Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 107, 6498-6503.
236. Weaver, I. C., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., and Meaney, M. J. (2004). Epigenetic programming by maternal behavior. Nat. Neurosci. 7, 847-854.
237. Wei, W., Zhang, N., Peng, Z., Houser, C. R., and Mody, I. (2003). Perisy-naptic localization of delta subunit-containing GABAA receptors and their activation by GABA spillover in the mouse dentate gyrus. J. Neurosci. 23, 10650-10661.
238. Weill-Engerer, S., David, J. P., Saz-dovitch, V., Liere, P., Eychenne, B., Pianos, A., Schumacher, M., Dela-courte, A., Baulieu, E. E., and Akwa, Y (2002). Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab. 87, 5138-5143.
239. Welberg, L. A., and Seckl, J. R. (2001). Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol. 13,113-128.
240. Wisden, W., Laurie, D. J., Monyer, H., and Seeburg, P. H. (1992). The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, dien-cephalon, mesencephalon. J. Neurosci. 12, 1040-1062.
241. Womack, M. D., Pyner, S., and Barrett-Jolley, R. (2006). Inhibition by α-tetrahydrodeoxycorticosterone (THDOC) of pre-sympathetic parvocellular neurones in the paraventricular nucleus of rat hypothalamus. Br. J. Pharmacol. 149,600-607.
242. Woolley, C. S., Gould, E., and McEwen, B. S. (1990). Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531, 225-231.
243. Zimmerberg, B., and Blaskey, L. G. (1998). Prenatal stress effects are partially ameliorated by prenatal administration of the neurosteroid allopregnanolone. Pharmacol. Biochem. Behav. 59, 819-827.
244. Zimmerberg, B., Brunelli, S. A., and Hofer, M. A. (1994). Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allopregnanolone. Pharmacol. Biochem. Behav. 47, 735-738.
245. Zimmerberg, B., and Kajunski, E. W. (2004). Sexually dimorphic effects of postnatal allopregnanolone on the development of anxiety behavior after early deprivation. Pharmacol. Biochem. Behav. 78, 465-471.
246. Zimmerberg, B., Rackow, S. H., and George-Friedman, K. P. (1999). Sex-dependent behavioral effects of the neurosteroid allopregnanolone (3α, 5α-THP) in neonatal and adult rats after postnatal stress. Pharmacol. Biochem. Behav. 64, 717-724.